99% Savings - Buy Just @1 Rs X
Terapress 5 Tablet is a commercial drug that is prescribed in the form of Tablet. It is typically used for the treatment of High BP. The alternative uses of Terapress 5 Tablet have also been explained below.
The right dosage of Terapress 5 Tablet depends on the age, gender, and medical history of the patient. The condition it has been prescribed for, and the route of administration also determine the right dosage. For detailed information on this, read through the dosage section.
The side effects typically associated with Terapress 5 Tablet include Nasal congestion, Sinus inflammation. Some other side effects of Terapress 5 Tablet have been listed ahead. Such side effects of Terapress 5 Tablet normally do not last long and go away once the treatment is completed. If, however, they worsen or do not go away, please speak with your physician.
In addition, Terapress 5 Tablet's effect is Severe during pregnancy and Severe for lactating mothers. In addition, Terapress 5 Tablet's effects on the liver, heart and kidney are discussed below in the Terapress 5 Tablet related warnings section.
Terapress 5 Tablet is not recommended if you suffer from certain medical conditions as it can have adverse effects. Low Blood Pressure (Hypotension) are examples of such conditions. The section on Terapress 5 Tablet contraindications lists all such conditions.
Drug interactions for Terapress 5 Tablet have been reported in the medical literature. Refer to the list below for further details.
You should also be aware that Terapress 5 Tablet is not safe while driving, and is not addiction.
Terapress 5 Tablet is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Terapress 5 Tablet safe for pregnant women?
Terapress should not be taken during pregnancy, or should only be taken on the advice of a doctor as it may have severe side effects.
Is the use of Terapress 5 Tablet safe during breastfeeding?
Terapress may cause serious side effects in breastfeeding women, so do not take this drug without doctor's advice.
What is the effect of Terapress 5 Tablet on the Kidneys?
Terapress does not damage the kidneys.
What is the effect of Terapress 5 Tablet on the Liver?
Terapress may have mild side effects on the liver. Most people will never see any effect on the liver.
What is the effect of Terapress 5 Tablet on the Heart?
Terapress may have mild side effects on the heart. Most people will never see any effect on the heart.
If you are suffering from any of the following diseases, you should not take Terapress 5 Tablet unless your doctor advises you to do so -
Is this Terapress 5 Tablet habit forming or addictive?
Forming a habit of Terapress 5 Tablet has not been reported.
Is it safe to drive or operate heavy machinery when consuming?
No, you should not drive or operate heavy machinery after taking Terapress 5 Tablet as you may feel sleepy.
Is it safe?
Terapress 5 Tablet is safe but it is important to consult a doctor before taking it.
Is it able to treat mental disorders?
Terapress 5 Tablet is unable to treat or cure mental disorders.
Interaction between Food and Terapress 5 Tablet
It is safe to take Terapress 5 Tablet with food.
Interaction between Alcohol and Terapress 5 Tablet
Taking alcohol with Terapress 5 Tablet can be dangerous.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Hytrin (terazosin hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 142
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1180-1182